Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy

Epilepsy and Behavior

Volumn 4, Issue 4, 2003, Pages 375-385

  Halford, J J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Contingent negative variation (CNV); Cordance low resolution electromagnetic tomography (LORETA); Electroencephalography (EEG); Loudness dependency of the auditory evoked potential (LDAEP); Magnetoencephalography (MEG); Mismatch negativity (MMN); P300; Quantitative electroencephalography (QEEG); Transcranial magnetic stimulation (TMS)

Indexed keywords

ANALYTIC METHOD; BRAIN TOMOGRAPHY; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; ECONOMIC ASPECT; ELECTROENCEPHALOGRAPHY; ELECTROMAGNETIC FIELD; EPILEPSY; EVOKED AUDITORY RESPONSE; EXPERIMENTATION; FRONTAL LOBE; GENETIC ANALYSIS; HUMAN; LATENT PERIOD; LOUDNESS; MAGNETOENCEPHALOGRAPHY; MEDICAL TECHNOLOGY; MENTAL DISEASE; MENTAL PATIENT; MISMATCH NEGATIVITY; NEUROPHYSIOLOGY; NON INVASIVE MEASUREMENT; PHENOTYPE; PREDICTION; PSYCHOLOGIC ASSESSMENT; QUANTITATIVE ANALYSIS; REVIEW; THETA RHYTHM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0042921412     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-5050(03)00148-3     Document Type: Review

References (175)

1. Nuwer M. Assessment of digital EEG, quantitative EEG and brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology 1997;49:277-92.
2. Hoffman DA, Lubar JF, Thatcher RW, et al. Limitations of the American Academy of Neurology and American Clinical Neurophysiology Society Paper on QEEG. J Neuropsychiatry Clin Neurosci 1999;11:401-7.
3. Hughes JR, John ER. Conventional and quantitative electroencephalography in psychiatry. J Neuropsychiatry Clin Neurosci 1999;11:190-208.
4. Jacobson SA, Leuchter AF, Walter DO. Conventional and quantitative EEG in the diagnosis of delerium amoung the elderly. J Neurol Neurosurg Psychiatry 1996;56(Suppl. 2):153-8.
5. Katz IR, Curyto KJ, TenHave T, Mossey J, Sands L, Kallan MJ. Validating the diagnosis of delerium and evaluating its association with deterioration over a one-year period. Am J Geriatr Psychiatry 2001;9:148-59.
6. Robinson DJ, Merskey H, Blume WT, Fry R, Williamson PC, Hachinski VC. Electroencephalography as an aid in the exclusion of Alzheimer's disease. Arch Neurol 1994;51(3):280-84.
7. Duffy FH, Albert MS, McAnulty G. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Ann Neurol 1984;16:439-48.
8. Martin-Loeches M, Gil P, Jimenez F, et al. Topographic maps of brain electrical activity in primary degenerative dementia of the Alzheimer type and multiinfact dementia. Biol Psychiatry 1991;29:211-23.
9. Yener GG, Leuchter AF, Jenden D, Read SL, Cummings JL, Miller BL. Quantitative EEG in frontotemporal dementia. Clin Electroencephalogr 1996;27(2):61-8.
10. Chabot RJ, di Michele F, Prichep L, John ER. The clinical role of computerized EEG in the evaluation and treatment of learning and attention disorders in children and adolescents. J Neuropsychiatry Clin Neurosci 2001;13:171-86.
11. Knott VJ, Lapierre YD. Computerized EEG correlates of depression and antidepressant treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 1987;11:213-21.
12. Pollock VE, Schneider LS. Quantitative, waking EEG research on depression. Biol Psychiatry 1990;27:757-80.
13. Nieber D, Schlegel S. Relationship between psychomotor retardation and EEG power spectrum in major depression. Neuropsychobiology 1992;25:20-3.
14. Schaffer CE, Davidson RH, Saron C. Frontal and parietal electroencephalogram asymmetry in depressed and nondepressed subjects. Biol Psychiatry 1982;18:753-62.
15. Henriques JB, Davidson RJ. Regional brain electrical assymetries discriminate between previously depressed and healthy control subjects. J Abnorm Psychol 1990;99:22-31.
16. Bruder GE, Fong R, Tenke C, et al. Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study. Biol Psychiatry 1997;41:939-48.
17. Reid SA, Duke LM, Allen JJB. Resting frontal electroencephalographic asymmetry in depression: inconsistencies suggest need to identify mediating factors. Psychophysiology 1998;35:389-404.
18. Ishii R, Shinosaki K, Ikejiri Y, et al. Theta rhythm increases in left superior temporal cortex during auditory hallucinations in schizophrenia: a case report. NeuroReport 2000;11:3283-7.
19. Ford JM, Mathalon DH, Whitfield S, Faustman WO, Roth WT. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol Psychiatry 2002;51:485-92.
20. Feinberg I, Guazzelli M. Schizophrenia: a disorder of the corollary discharge systems that integrate the motor systems of thought with the sensory systems of consciousness. Br J Psychiatry 1999;174:196-204.
21. Li CS, Chen MC, Yang YY, Chen MC, Tsay PK. Altered performance of schizophrenia patients in an auditory detection and discrimination task: exploring the 'self-monitoring' model of hallucination. Schizophrenia Res 2002;55:115-28.
22. Leuchter AF, Cook IA, Lufkin RB, et al. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage 1994;1:208-19.
23. Leuchter AF, Uijtdehaage SHJ, Cook IA, O'Hara R, Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res Neuroimaging Sect 1999;90:125-40.
24. Cook IA, O'Hara R, Uijtdehaage SHJ, Mandelkern M, Leuchter AF. Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalogr Clin Neurophysiol 1998;107:408-14.
25. Cook IA, Leuchter AF, Uijtdehaage SHJ, et al. Altered cerebral energy utilization in late life depression. J Affect Disord 1998;49:89-99.
26. Cook IA, Leuchter AF, Witte E, et al. Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Res 1999;85:263-73.
27. Leuchter AF, Cook IA, Witte E, Morgan M, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 2002;159:122-9.
28. Pascual-Marqui RD, Michel CM, Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int J Psychophysiol 1994;18:49-65.
29. Pascual-Marqui RD. Low resolution brain electromagnetic tomography (LORETA). Electroencephalogr Clin Neurophysiol 1997;103:36.
30. Lantz G, Michel CM, Pascual-Marqui RD, et al. Extracranial localization of intracranial interictal epileptiform activity using LORETA (low resolution electromagnetic tomography). Electroencephalogr Clin Neurophysiol 1997;102:414-22.
31. Fernandez-Bouzas A, Casanova R, Harmony T. EEG frequency-domain distributed inverse solutions in brain lesions. Electroencephalogr Clin Neurophysiol 1997;103:195.
32. Harmony T, Fernandez-Bouzas A, Marosi E, et al. Frequency source analysis in patients with brain lesions. Brain Topogr 1995;8:109-17.
33. Sgouros S, Seri S, Natarajan K. The clinical value of electroencephalogram/magnetic resonance imaging co-registration and three-dimensional construction in the surgical treatment of epileptogenic lesions. Childs Nervous System 2001;17:139-44.
34. Worrell GA, Lagerlund TD, Sharbrough FW, et al. Localization of the epileptic focus by low-resolution electromagnetic tomography in patients with a lesion demonstrated by MRI. Brain Topogr 2000;12:273-82.
35. Pizzagalli DA, Nitschke JB, Oakes TR, et al. Brain electrical tomography in depression: the importance of symptom severity, anxiety, and melancholic features. Biol Psychiatry 2002;52:73-85.
36. Mientus S, Gallinat J, Wuebben Y, et al. Cortical hypoactivation during resting EEG in schizophrenics but not depressives and schizotypal subjects as revealed by low resolution electromagnetic tomotography (LORETA). Psychiatry Res Neuroimaging Sect 2002;116:95-111.
37. Saletu B, Anderer P, Saletu-Zyhlarz GM, Pascual-Marqui RD. EEG tomography and topography in diagnosis and treatment of mental disorders: evidence for a key-lock principle. Methods Find Exp Clin Pharmacol 2002;24(Suppl. D):97-106.
38. Mulert C, Juckel G, Augustin H, Hegerl U. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment responce to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 2002;113:1566-72.
39. Mulert C, Gallinat J. Reduced event-related current density in the anterior cingulate cortex in schizophrenia. Neuroimage 2001;13:589-600.
40. Winterer G, Mulert C, Mientus S, et al. P300 and LORETA: comparison of normal subjects and schizophrenic patients. Brain Topogr 2001;13:299-313.
41. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001;158:405-15.
42. Ishihara T, Yoshi N. Multivariate analytic study of EEG and mental activity in juvenile delinquents. Electroencephalogr Clin Neurophysiol 1972;33:71-80.
43. Ishii R, Shinosaki K, Ukai S, et al. Medial prefrontal cortex generates frontal midline theta rhythm. NeuroReport 1999;10:675-9.
44. Kubota Y, Sato W, Toichi M, et al. Frontal midline theta rhythm is correlated with cardiac autonomic activities during the performance of an attention demanding meditation procedure. Cogn Brain Res 2001;11:281-7.
45. Dietl T, Dirlich G, Vogl L, Lechner C, Strian F. Orienting response and frontal midline theta activity: a somatosensory spectral perturbation study. Clin Neurophysiol 1999;110:1204-9.
46. Basar E, Schurmann M, Sakowitz O. The selectively distributed theta system: functions. Int J Psychophysiol 2001;39:197-212.
47. Klimesch W, Doppelmayr M, Schimke H, Ripper B. Theta synchronization and alpha desynchronization in a memory task. Psychophysiology 1997;34:169-76.
48. Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res 1999;29:169-95.
49. Yamamoto S, Matsuoka S. Topographic EEG study of visual display terminal (VDT) performance with special reference to frontal midline theta waves. Brain Topogr 1990;4:257-67.
50. Inanaga K. Frontal midline theta rhythm and mental activity. Psychiatry Clin Neurosci 1998;52:555-66.
51. Slobounov SM, Fukada K, Simon R, Rearick M, Ray W. Neurophysiologic, and behavioral indices of time pressure effects on visuomotor task performance. Cogn Brain Res 2000;9:287-98.
52. Mizuki Y, Tanaka M, Isozaki H, Nishijima H, Inanaga K. Periodic appearance of theta rhythm in the frontal midline area during performance of a mental task. Electroencephalogr Clin Neurophysiol 1980;49:345-51.
53. Gevins A, Smith ME, McEvoy LK, Yu D. High-resolution EEG mapping of cortical activation related to working memory: effects of task difficulty, type of processing, and practice. Cereb Cortex 1997;7:374-85.
54. Asada H, Fukada Y, Tsunoda S, Yamaguchi M, Tonoike M. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neurosci Lett 1999;274:29-32.
55. Vrba J, Robinson SE. Signal processing in magnetoencephalography. Methods 2001;25:249-71.
56. Mokran V, Ciganek L, Kabatnik Z. Electroencephalographic theta discharges in the midline. Eur Neurol 1971;5:288-93.
57. Ciganek L. Theta-discharges in the middle-line: EEG symptom of temporal lobe epilepsy. Electroencephalogr Clin Neurophysiol 1961;13:669-73.
58. Westmoreland BF, Klass DW. Midline theta rhythm. Arch Neurol 1986;43:139-41.
59. Pellouchoud E, Smith ME, McEvoy LK, Gevins A. Mental effort-related EEG modulation during video-game play: comparison between juvenile subjects with epilepsy and normal control subjects. Epilepsia 1999;40(Suppl. 4):38-43.
60. Tripodianakis J, Markianos M, Saratidis D, Spyropoulou G, Taktikou V, Bistolaki E. Platelet MAO activity in patients with dysthymic disorder. Psychiatry Res 1998;78:173-78.
61. Hashimoto M, Mukasa H, Yamada S, Makamura J, Inanaga K. Frontal midline theta and platelet MAO in human subjects. Biol Psychiatry 1988;23:31-43.
62. Suetsugi M, Mizuki Y, Ushijima I, et al. Appearance of frontal midline theta activity in patients with generalized anxiety disorder. Neuropsychobiology 2000;41:108-12.
63. Suetsugi M, Mizuki Y, Uchijima I, Yamada M, Imaizumi J. Anxiolytic effects of low-dose clomipramine in highly anxious healthy volunteers assessed by frontal midline theta activity. Prog Neuro-Psychopharmacol Biol Psychiatry 1998;22:97-112.
64. Aftanas LI, Golocheikine SA. Human anterior and frontal midline theta and lower alpha reflect emotionally positive state and internal attention: high-resolution EEG investigation of medititation. Neurosci Lett 2001;310:57-60.
65. Knott VJ, Telner JI, Lapierre YD, Browne M, Horn BR. Quantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord 1996;39:175-84.
66. Ottowitz WE, Dougherty DD, Savage CR. The neural network basis for abnormalities of attention and executive function in major depressive disorder: implications for application of medical disease model to psychiatric disorders. Harvard Rev Psychiatry 2002;10:86-99.
67. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behavior. Brain 1995;118:279-306.
68. Yee CM, Nuechterlein KH, Morris SE, White PM. P50 Suppression in recent-onset schizophrenia: clinical correlates and risperidone effects. J Abnorm Psychol 1998;107:691-8.
69. Freedman R, Adler LE, Myles-Worsley M, et al. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenia and normal subjects: human recordings, computer simulation, and an animal model. Arch Gen Psychiatry 1996;53:1114-21.
70. Erwin RJ, Turetsky BI, Moberg RC, Gur RC, Gur RE. P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophrenia Res 1998;33:157-67.
71. Waldo MC, Cawthra E, Adler LE, et al. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophrenia Res 1994;12:93-106.
72. Waldo M, Myles-Worsley M, Madison A, Byerley W, Freedman R. Sensory gating deficits in parents of schizophrenics. Am J Med Genet 1995;60:506-11.
73. Clementz BA, Geyer MA, Braff DL. P50 suppression among the relatives of schizophrenia patients. Schizophrenia Res 1997;24:232.
74. Coon H, Plaeke R, Holik J, et al. Use of a neurophysiological train in linkage analysis of schizophrenia. Biol Psychiatry 1993;34:277-89.
75. Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997;94:587-92.
76. Leonard S, Gault J, Hopkins J, et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 2002;59:1085-96.
77. Raux G, Bonnet-Brilhault F, Louchart S, et al. The -2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit. Mol Psychiatry 2002;7:1006-11.
78. Reite M, Adams M, Simon J, et al. Auditory M100 component 1: relationship to Heschl's gyrus. Cogn Brain Res 1994;2:13-20.
79. Pantev C, Bertrand O, Eulitz C, et al. Specific tonotopic organizations of different areas of the human auditory cortex revealed by simultaneous magnetic and electrical recordings. Electroencephalogr Clin Neurophysiol 1995;94:26-40.
80. Frodl T, Meisenzahl EM, Gallinat J, Hegerl U, Moller HJ. Markers from event-related potential subcomponents and reaction time for information processing dysfunction in schizophrenia. Eur Arch Psychiatry Clin Neurosci 1998;248:307-13.
81. Ford JM, Mathalon DH, Marsh L. P300 amplitude is related to clinical state in severely and moderately ill schizophrenics. Biol Psychiatry 1999;46:94-101.
82. Pfefferbaum A, Ford JM, White PM, Roth WT. P3 in schizophrenia is affected by stimulus modality, response requirements, medication status and negative symptoms. Arch Gen Psychiatry 1989;46:1035-46.
83. Shelley A, Silipo G, Javitt D. Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction. Schizophrenia Res 1999;37:65-79.
84. Teale P, Reite M, Rojas DC, Sheeder J, Arciniegas D. Fine structure of the auditory M100 in schizophrenia and schizoaffective disorder. Biol Psychiatry 2000;48:1109-12.
85. Ford JM, Mathalon DH, Kalba S, Marsh L, Pfefferbaum A. N1 and P300 abnormalities in patients with schizophrenia, epilepsy, and epilepsy with schizophrenialike features. Biol Psychiatry 2001;49:848-60.
86. Verlager R, Lefebre C, Wieschemeyer R, Kompt D. Event-related potentials suggest slowing of brain processees in generalized epilepsy and alterations of visual processing in patients with partial seizures. Cogn Brain Res 1997;5:205-19.
87. Ford JM, Mathalon DH, Kalba S, Whitfield S, Faustman WO, Roth WT. Cortical responsiveness during talking and listening in schizophrenia: an event-related brain potential study. Biol Psychiatry 2001;50:540-9.
88. Hegerl U, Juckel G. Intensity dependence of the auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993;33:173-87.
89. Azmitia EC, Gannon PJ. The primate serotonergic system: a review of human and animal studies and a report on macaca fascicularis. Adv Neurol 1886;43:407-68.
90. Lewis DA, Campbell MJ, Foote SL, Morrison JH. The monoaminergic innervation of primate neocortex. Hum Neurobiol 1986;5:181-8.
91. Campbell MJ, Lewis DA, Foote SL, Morrison JH. Distribution of choline acetyltransferase-, serotonin-, dopamine-, β-hydroxylase-, tyrosine hydroxylase-immunoreactive fibers in monkey primary auditory cortex. J Comp Neurol 1987;261:209-20.
92. Rouiller EM, Hornung JP, De Ribaupierre F. Extrathalamic ascending projections to physiologically identified fields of the cat auditory corex. Hearing Res 1989;40:233-46.
93. Brown RM, Crane AM, Goldman PS. Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates. Brain Res 1979;168:133-50.
94. von Knorring L, Perris C. Biochemisty of augmenting response of visual-evoked potentials. Neuropsychobiology 1981;7:1-8.
95. von Knorring L, Johansson F, Almay B. Augmenting/reducing response in visual evoked potentials in patients with chronic pain syndromes. Adv Biol Psychiatry 1980;4:55-62.
96. Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenhein M, Moller HJ. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998;248:96-103.
97. Anthony M, Hinterberger H, Lance JW. The possible relationship of serotonin to the migraine syndrome. In: Friedman AP, editor. Research and clinical studies in headache. New York: Karger; 1969. p. 29-59.
98. Wang W, Timsit-Berthier M, Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996;46:1404-9.
99. Wang W, Wang Y, Fu X, Sun Z, Schoenen J. Auditory evoked potentials and multiple personality measures in migraine and post-traumatic headaches. Pain 1999;79:235-42.
100. Afra J, Cecchini AP, Sandor PS, Schoenen J. Comparison of visual and auditory evoked cortical potentials in migraine patients between attacks. Clin Neurophysiol 2000;111:1124-9.
101. Tuchtenhagen F, Daumann J. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmocology 2000;22:608-17.
102. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G. Auditory-evoked potentials as indicator of brain serotonergic activity: first evidence in behaving cats. Biol Psychiatry 1997;41:1181-95.
103. Gallinat J, Bottlender R, Juckel G, et al. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology 2000;148:404-11.
104. Paige SR, Fitzpatrick DF, Kline JP, Balogh SE, Hendricks SE. Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology 1994;30:197-201.
105. Mathalon DH, Ford JM. The long and short of it: influence of interstimulus interval on auditory P300 abnormalities in schizophrenia. Clin Electroencephalogr 2002;33:125-35.
106. Hansenne M, Pitchot W, Pinto E, Reggers J, Papart P, Ansseau M. P300 event-related potential and personality in depression. Eur Psychiatry 2000;15:370-7.
107. Roth WT, Cannon EH. Some features of the auditory evoked responce in schizophrenics. Arch Gen Psychiatry 1972;27:466-71.
108. Nichols JM, Martin F. P300 in heavy social drinkers: the effect of lorazepam. Alcohol 1993;10:269-74.
109. Mathalon DH, Ford JM, Rosenbloom M, Pfefferbaum A. P300 reduction and prolongation with illness duration in schizophrenia. Biol Psychiatry 2000;47:413-27.
110. Saitoh O, Niwa S, Hiramatsu K, Kameyama T, Rymar K, Itoh K. Abnormalities in late positive components of event-related potentials may reflect a genetic predisposition to schizophrenia. Biol Psychiatry 1984;19:293-303.
111. d'Amato T, Karoumi B, Rosenfeld F, Saoud M, Brunon AM, Dalery J. Vulnerability to schizophrenia: II. Familial status of auditory evoked potential abnormalities. Encephale 1999;25:288-95.
112. Friedman D, Vaughan HG, Erlenmeyer-Kimling L. Cognitive brain potentials in children at risk for schizophrenia, preliminary findings. Schizophrenia Bull 1982;8:514-31.
113. Mathalon DH, Ford JM, Pfefferbaum A. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol Psychiatry 2000;47:434-49.
114. Turetsky B, Colbath EA, Gur RE. P300 subcomponent abnormalities in schizophrenia: II. Longitudinal stabillity and relationship to symptom change. Biol Psychiatry 1998;43:31-9.
115. Higashima M, Nagasawa T, Yasubiro K, et al. Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: cross-sectional and retrospective longitudinal studies. Schizophrenia Res 2002;59:147-57.
116. O'Donnell BF, Faux SF, McCarley RW, et al. Increased rate of P300 prolongation with age in schizophrenia: electrophysiological evidence for a neurodegenerative process. Arch Gen Psychiatry 1995;52:544-9.
117. Strik WK, Dierks T, Franzek E, Stober G, Maurer K. P300 Asymmetries in schizophrenia revisited with reference-independent methods. Psychiatry Res Neuroimaging 1994;55:153-66.
118. Potts GF, Hirayasu Y, O'Donnell BF, Shenton ME, McCarley RW. High-density recording and topographic analysis of the auditory oddball event-related potential in patients with schizophrenia. Biol Psychiatry 1998;44:982-9.
119. Iwanami A, Yamashina M, Kazamatsuri H, Kamijima K. P300 and disability of daily life in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 1999;23:423-30.
120. Higashima M, Urata K, Kawasaki Y, et al. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia. Biol Psychiatry 1998;44:115-20.
121. Roschke J, Wagner P, Mann J, Fell M, Grozinger M, Frank C. Single trial analysis of event related potentials: a comparison between schizophrenics and depressives. Biol Psychiatry 1996;40:844-52.
122. Anderer P, Saletu B, Semlitsch HV, Pascual-Marqui RD. Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugs. Methods Find Exp Clin Pharmacol 2002;24(Suppl. D):85-91.
123. Yanai I, Fujikawa T, Osada M, Yamawaki S, Touhouda Y. Changes in auditory P300 in patients with major depression and silent cerebral infarction. J Affect Disord 1997;46:1997.
124. Karaaslan F, Gonul AS, Oguz A, Erdinc E, Esel E. P300 changes in major depressive disorders with and without psychotic features. J Affect Disord 2003;73:283-7.
125. Bruder GE, Towey JP, Stewart JW, Friedman D, Tenke C, Quitkin FM. Event-related potentials in depression: influence of task, stimulus hemifield and clinical features to P3 latency. Biol Psychiatry 1991;30:233-46.
126. Kaustio O, Partanen J, Valkonen-Korhonen M, Viinamaki H, Lehtonen J. Affective and psychotic symptoms relate to different types of P300 alterations in depressive disorder. J Affect Disord 2002;71:2002.
127. Himani A, Tandon OP, Bhatia MS. A study of P300-event related potentials in the patients of major depression. Indian J Physiol Pharmacol 1999;43:367-72.
128. Santosh PJ, Malhotra S, Raghunathan M, Mehra YN. A Study of P300 in melancholic depression: correlation with psychotic features. Biol Psychiatry 1994;35:474-9.
129. Kalayam B, Alexopoulos GS. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 1999;56:713-8.
130. Bauer LO, Costa L, Hesselbrock VM. Effects of alcoholism, anxiety and depression on P300 in women: a pilot study. J Stud Alcohol 2001;62:571-9.
131. Ortiz AT, Lopez-Ibor MI, Martinez CE, Fernandez LA, Maestu UF, Lopez-Ibor JJ. Deficit in sensory motor processing in depression and Alzheimer's disease: a study with EMG and event related potentials. Electromyogr Clin Neurophysiol 2000;40:357-63.
132. Puce A, Bladin PF. Scalp and limbic P3 event-related potentials in the assessment of patients with temporal lobe epilepsy. Epilepsia 1991;32:629-34.
133. Triantafyllou N, Zalonis I, Kokosis P, Anthracopoulos M, Siafacas A, Malliara S. Cognition in epilepsy: a multichannel event related potential. Acta Neurol Scand 1992;86:462-5.
134. Kasai K, Nakagome K, Itoh K, et al. Impaired cortical network for preattentive detection of change in speech sounds in schizophrenia: a high-resolution event-related potential study. Am J Psychiatry 2002;159:546-53.
135. Kasai K, Okazawa K, Nakagome K, et al. Mismatch negativity and N2b attenuation as an indicator for dysfunction of the preattentive and controlled processing for deviance detection in schizophrenia: a topographic event-related potential study. Schizophrenia Res 1999;35:141-56.
136. Javitt DC, Shelley A-M, Ritter W. Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clin Neurophysiol 2000;111:1733-7.
137. Javitt D, Shelley A-M, Silipo G, Lieberman JA. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Arch Gen Psychiatry 2000;57:1131-7.
138. Shelley AM, Ward PB, Catts SV, Michie PT, Andrews S, McConaghy N. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry 1991;30:1059-62.
139. Kreitschmann-Andermahr I, Rosburg T, Meier T, Volz HP, Nowak H, Sauer H. Impaired sensory processing in male patients with schizophrenia: a magnetoencephalographic study of auditory mismatch detection. Schizophrenia Res 1999;35:121-9.
140. O'Donnell BF, Hokama H, McCarley RW, et al. Auditory ERPs to non-target stimuli in schizophrenia: relationship to probability, task demand, and target ERPs. Int J Psychophysiol 1994;17:219-31.
141. Kasai K, Yamada M, Kamio S, et al. Neuromagnetic correlates of impaired automatic categorical perception of speech sounds in schizophrenia. Schizophrenia Res 2002;59:159-72.
142. Olbrich HM, Maes H, Valerius G, Langosch JM, Horst G, Feige B. Assessing cerebral dysfunction with probe-evoked potentials in a CNV task: a study in alcoholics. Clin Neurophysiol 2002;113:815-25.
143. Neylan TC, Reynolds CF, Kupfer DJ. Electrodiagnostic techniques in neuropsychiatry. In: Yudofsky SC, Hales RE, editors. The American Psychiatric Press textbook of neuropsychiatry. Washington, DC: American Psychiatric Press; 1997. p. 165-79.
144. Rugg MD, Cowan CP, Nagy ME, Milner AD, Jacobson I, Brooks DN. CNV abnormalities following closed head injury. Brain 1989;112:489-506.
145. Heimberg DR, Naber G, Hemmeter U, et al. Contingent negative variation and attention in schizophrenic and depressed patients. Neuropsychobiology 1999;39:131-40.
146. Oke S, Saatchi R, Allen E, Hudson NR, Jervis BW. The contingent negative variation in positive and negative types of schizophrenia. Am J Psychiatry 1994;151:432-3.
147. Giedke H, Bolz J. Pre- and postimperative negative variation (CNV and PINV) under different conditions of controllability in depressed patients and healthy controls. Prog Brain Res 1980;54:579-82.
148. Ashton CH, Golding JF, Marsh VR, Thompson JW, Hassanyeh F, Tyrer SP. Cortical evoked potentials and clinical rating scales as measures of depressive illness. Psychol Med 1988;18:305-17.
149. Bolz J, Giedke H. Controllability of an aversive stimulus in depressed patients and healthy controls: a study using slow brain potentials. Biol Psychiatry 1981;16:441-52.
150. Elton M. A longitudinal investigation of event-related potentials in depression. Biol Psychiatry 1984;19:1635-49.
151. Knott VJ, Lapierre YD. Electrophysiological and behavioral correlates of psychomotor responsitivity in depression. Biol Psychiatry 1987;22:313-24.
152. Papart P, Ansseau M, Devoitille JM, Manatanus M, Timsit-Berthier M. Contingent negative variation and severity of depression. In: Stephanis CN, Rabavilas AD, Soldatos CR, editors. Psychiatry: a world perspective. Amsterdam: Elsevier Science; 1990. p. 402-8.
153. Hemmeter U, Heimberg DR, Naber G, Hobi V, Holsboer-Trachsler E. Contingent negative variation and Dex-CRH test in patients with major depression. J Psychiatr Res 2000;34:365-7.
154. Timsit-Berthier M, Ansseau M, Manatanus M, Legros JJ. Current use of contingent negative variation and dexamethasone suppression test in major depression. In: Shagass C, Josiassen RC, Roemer RA, editors. Electric potentials and psychopathy. New York: Elsevier: 1986. p. 245-58.
155. Ashton CH, Marshall EF, Hassanyeh F, Marsh VR. Biological correlates of deliberate self-harm behavior: a study of electroencephalographic, biochemical and psychological variables in parasuicide. Acta Psychiatr Scand 1994;90:316-23.
156. Hansenne M, Pitchot W, Moreno AG, Zaldua IU, Ansseau M. Suicidal behavior in depressive disorder: an event-related potential study. Biol Psychiatry 1996;40:116-22.
157. Puri BK, Davey NJ, Ellaway PH, Lewis SW. An investigation of motor function in schizophrenia using transcranial magnetic stimulation of the motor cortex. Br J Psychiatry 1996;169: 690-5.
158. Curra A, Modugno N, Inghilleri M, Manfredi M, Hallett M, Berardelli A. Transcranial magnetic stimulation techniques in clinical investigation. Neurology 2002;59:1851-9.
159. Daskalakis ZJ, Christensen BK, Fritzgerald PB, Chen R. Transcranial magnetic stimulation: a new investigational tool in psychiatry. J Neuropsychiatry Clin Neurosci 2002;14:406-15.
160. Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 2002;59:347-54.
161. Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after the motor evoked potential. Electroencephalogr Clin Neurophysiol 1991;81:257-62.
162. Inghilleri M, Berardelli A, Cruccu G, Manfredi M. Silent period evoked by transcranial stimulation of the human corex and cervicomedullary junction. J Physiol 1993;466.
163. Nakamura H, Kitagawa H, Kawaguchi Y, Tsuji H. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol 1997;498:817-23.
164. Fitzgerald PB, Brown TL, Daskalakis ZJ, Kulkarni J. A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia. Psychiatry Res 2002;114:11-22.
165. Ziemann U, Paulus W, Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 1997;154:1277-84.
166. Wasserman EM, Greenberg BD, Nguyen MB, Murphy DL. Motor cortex excitability correlates with an anxiety-related personality trait. Biol Psychiatry 2001;50.
167. Maeda Y, Keenan JP, Pascual-Leone A. Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation. Br J Psychiatry 2000;177:169-73.
168. Greenberg BD, Ziemann U, Cora-Locatelli G, et al. Altered cortical excitability in obsessive-compulsive disorder. Neurology 2000;54:142-7.
169. Kessler KR, Schnitzler A, Classen J, Benecke R. Reduced inhibition within primary motor cortex in patients with post-stroke focal motor seizures. Neurology 2002;59:1028-33.
170. Irlbacher K, Brandt SA, Meyer BU. In vivo study indicating loss of intracortical inhibition in tumor-associated epilepsy. Ann Neurol 2002;52:119-22.
171. Manganotti P, Tamburin S, Zanette G, Fiaschi A. Hyperexcitable cortical responses in progressive myoclonic epilepsy. Neurology 2001;57:1793-9.
172. Valzania F, Strafella AP, Tropeneani A, Rubboli G, Nassetti SA, Tassinari CA. Facilitation of rhythmic events in progressive myoclonic epilepsy: a transcranial magnetic stimulation study. Clin Neurophysiol 1999;110:152-7.
173. Macdonell RAL, King MA, Newton MR, Curatolo JM, Reutens DC. Prolonged cortical silent period after transcranial magnetic stimulation in generalized epilepsy. Neurology 2001;57:706-8.
174. Werhahn KJ, Lieber J, Classen J, Noachtar S. Motor cortex excitability in patients with focal epilepsy. Epilepsy Res 2000;41:179-81.
175. Cantello R, Civardi C, Cavalli A, et al. Cortical excitability in cryptogenic localization-related epilepsy: interictal transcranial magnetic stimulation studies. Epilepsia 2000;41:694-704.